RESÚMENES JULIO 2008

.

Addictive Disorders

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism

Raúl Pastor, Carrie S. McKinnon, Angela C. Scibelli, Sue Burkhart-Kasch, Cheryl Reed, Andrey E. Ryabinin, Sarah C. Coste, Mary P. Stenzel-Poore, and Tamara J. Phillips

PNAS July 1, 2008 vol. 105 no. 26 9070-9075

 

3 - Amygdala Volume Associated With Alcohol Abuse Relapse and Craving

Jana Wrase, Nicos Makris, Dieter F. Braus, Karl Mann, Michael N. Smolka, David N. Kennedy, Verne S. Caviness, Steven M. Hodge, Lena Tang, Matthew Albaugh, David A. Ziegler, Orin C. Davis, Christian Kissling, Gunter Schumann, Hans C. Breiter, and Andreas Heinz

Am J Psychiatry Published July 1, 2008

3! - Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study

Michael Soyka, Christina Zingg, Gabriele Koller and Heinrich Kuefner

The International Journal of Neuropsychopharmacology (2008), 11:641-653

 

2 - Deep Brain Stimulation in the Context of Addiction - A Literature-Based Systematic Evaluation

R.  Bauer, S.  Pohl, J.  Klosterkötter, J.  Kuhn

Fortschr Neurol Psychiatr 2008; 76: 396-401

3 - Preliminary Study of Buprenorphine and Bupropion for Opioid-Dependent Smokers

Marc E. Mooney;  James Poling;  Gerardo Gonzalez;  Kishor Gonsai;  Thomas Kosten; Mehmet Sofuoglu

American Journal on Addictions, Volume 17, Issue 4 July 2008, pages 287 - 292

 

3 - Infrequent Illicit Methadone Use Among Stimulant-Using Patients in Methadone Maintenance Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network Study

Li-Tzy Wu;  Dan G. Blazer;  Maxine L. Stitzer;  Ashwin A. Patkar; Jack D. Blaine

American Journal on Addictions, Volume 17, Issue 4 July 2008, pages 304 - 311

 

3 - Olanzapine Reduces Urge to Smoke and Nicotine Withdrawal Symptoms in Community Smokers

Damaris J. Rohsenow, Jennifer W. Tidey, Robert Miranda Jr., John E. McGeary, Robert M. Swift, Kent E. Hutchison, Alan D. Sirota and Peter M. Monti

Experimental and Clinical Psychopharmacology. Volume 16, Issue 3, June 2008, Pages 215-222

 

3 - The Prevalence of Borderline Personality among Buprenorphine Patients

Randy A. Sansone, Phillip Whitecar, Michael W. Wiederman

The International Journal of Psychiatry in Medicine. Volume 38, Number 2 / 2008:217 - 226

 

3! - Role of individual, peer and family factors in the use of cannabis and other illicit drugs: A longitudinal analysis among Finnish adolescent twins

Tellervo Korhonen, Anja C. Huizink, Danielle M. Dick, Lea Pulkkinen, Richard J. Rose and Jaakko Kaprio

Drug and Alcohol Dependence. Volume 97, Issues 1-2, 1 September 2008, Pages 33-43

 

5 - A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal

Elmer Yu, Karen Miotto, Evaristo Akerele, Ann Montgomery, Ahmed Elkashef, Robert Walsh, Ivan Montoya, Marian W. Fischman, Joseph Collins, Frances McSherry, Kathy Boardman, David K. Davies, Charles P. O’Brien, Walter Ling, Herbert Kleber and Barbara H. Herman

Drug and Alcohol Dependence. Volume 97, Issues 1-2, 1 September 2008, Pages 158-168

 

3! - Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: A European multicenter study

Isabel Krug, Janet Treasure, Marija Anderluh, Laura Bellodi, Elena Cellini, Milena di Bernardo, Roser Granero, Andreas Karwautz, Benedetta Nacmias, Eva Penelo, Valdo Ricca, Sandro Sorbi, Kate Tchanturia, Gudrun Wagner, David Collier and Fernando Fernández-Aranda

Drug and Alcohol Dependence. Volume 97, Issues 1-2, 1 September 2008, Pages 169-179

 

3 - The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice

Robert Malcolm, M Foster Olive & William Lechner

Expert Opinion on Drug Safety. July 2008, Vol. 7, No. 4, Pages 459-472

 

GRATIS 3! - Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials

Mark J. Eisenberg, Kristian B. Filion, Daniel Yavin, Patrick Bélisle, Salvatore Mottillo, Lawrence Joseph, André Gervais, Jennifer O'Loughlin, Gilles Paradis, Stephane Rinfret, and Louise Pilote

CMAJ • July 15, 2008; 179 (2)

3! - Pharmacotherapy for Methamphetamine Dependence: A Review of the Pathophysiology of Methamphetamine Addiction and the Theoretical Basis and Efficacy of Pharmacotherapeutic Interventions

Mark E. Rose; Jon E. Grant

Annals of Clinical Psychiatry, Volume 20, Issue 3 August 2008, pages 145 - 155

 

GRATIS (previa suscripción) 3 - Varenicline and Its Role in Smoking Cessation

Shailendra Kapoor

Prev Cardiol. 2008 Summer;11(3):168-171

 

3 - Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA

F Hasler, E Studerus, K Lindner, S Ludewig, and FX Vollenweider

Journal of Psychopharmacology. First published on July 17, 2008

3 - Ethanol Modulates Synaptic and Extrasynaptic GABAA Receptors in the Thalamus

Fan Jia, Dev Chandra, Gregg E. Homanics, and Neil L. Harrison

JPET 326:475-482, 2008

 

3 - The Endogenous Cannabinoid System Modulates Nicotine Reward and Dependence

Lisa L. Merritt, B. R. Martin, C. Walters, A. H. Lichtman, and M. Imad Damaj

JPET 326:483-492, 2008

 

3 - Brain Regional Differences in the Effect of Ethanol on GABA Release from Presynaptic Terminals

Hugh E. Criswell, Zhen Ming, M. Katherine Kelm, and George R. Breese

JPET 326:596-603, 2008

 

5 - Improvement of Physical Health and Quality of Life of Alcohol-Dependent Individuals With Topiramate Treatment. US Multisite Randomized Controlled Trial

Bankole A. Johnson, Norman Rosenthal, Julie A. Capece, Frank Wiegand, Lian Mao, Karen Beyers, Amy McKay, Nassima Ait-Daoud, Giovanni Addolorato, Raymond F. Anton, Domenic A. Ciraulo, Henry R. Kranzler, Karl Mann, Stephanie S. O’Malley, Robert M. Swift, for the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group

Arch Intern Med. 2008;168(11):1188-1199

 

GRATIS 3! - The alcohol withdrawal syndrome

A McKeon, M A Frye, Norman Delanty

Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:854-862

3 - Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment

Robert James Tait,  Hanh Thi Thu Ngo, Gary Kenneth Hulse

J Subs Abuse Treat. Volume 35, Issue 2, Pages 116-124 (September 2008)

 

3! - Outcomes of neonates conceived on methadone maintenance therapy

John J. McCarthy, Martin H. Leamon, Garrett Stenson, Lagen A. Biles

J Subs Abuse Treat. Volume 35, Issue 2, Pages 202-206 (September 2008)

 

3 - Violence perpetration and childhood abuse among men and women in substance abuse treatment

Mandi L. Burnette, Mark Ilgen, Susan M. Frayne, Emma Lucas, Julia Mayo, Julie C. Weitlauf

J Subs Abuse Treat. Volume 35, Issue 2, Pages 217-222 (September 2008)

 

3 - Treatment with Clomethiazole is Associated with Lower Rates of Premature Discharge during Alcohol Withdrawal

T. Hillemacher, C. Weinland, A. Heberlein, J. Wilhelm, K. Bayerlein, J. Kornhuber, H. Frieling, S. Bleich

Pharmacopsychiatry 2008; 41: 134-137

3 - Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats

Jorge Camarasa, José M. Marimón, Teresa Rodrigo, Elena Escubedo and David Pubill

European Journal of Pharmacology. Volume 589, Issues 1-3, 28 July 2008, Pages 132-139

 

GRATIS 3! - Toward a Global View of Alcohol, Tobacco, Cannabis, and Cocaine Use: Findings from the WHO World Mental Health Surveys

Louisa Degenhardt, Wai-Tat Chiu, Nancy Sampson, Ronald C. Kessler, James C. Anthony, Matthias Angermeyer, Ronny Bruffaerts, Giovanni de Girolamo, Oye Gureje, Yueqin Huang, Aimee Karam, Stanislav Kostyuchenko, Jean Pierre Lepine, Maria Elena Medina Mora, Yehuda Neumark, J. Hans Ormel, Alejandra Pinto-Meza, José Posada-Villa, Dan J. Stein, Tadashi Takeshima, J. Elisabeth Wells

PLoS Med 5(7): e141

 

3 - Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: Converging evidence from human and animal research

George S. Portugal and Thomas J. Gould

Behavioural Brain Research. Volume 193, Issue 1, 3 November 2008, Pages 1-16

 

3! - Cocaine but Not Natural Reward Self-Administration nor Passive Cocaine Infusion Produces Persistent LTP in the VTA

Billy T. Chen, M. Scott Bowers, Miquel Martin, F. Woodward Hopf, Anitra M. Guillory, Regina M. Carelli, Jonathan K. Chou and Antonello Bonci

Neuron. Volume 59, Issue 2, 31 July 2008, Pages 288-297

 

3 - Repeated cocaine administration increases N-methyl-d-aspartate NR1 subunit, extracellular signal-regulated kinase and cyclic AMP response element-binding protein phosphorylation and glutamate release in the rat dorsal striatum

Dong Kun Lee, Shengjie Bian, Md. Aminur Rahman, Yoon-Bo Shim, Insop Shim and Eun Sang Choe

European Journal of Pharmacology. Volume 590, Issues 1-3, 20 August 2008, Pages 157-162

 

GRATIS - Chantix® (varenicline) tablets

HIGHLIGHTS OF PRESCRIBING INFORMATION

 FDA approved labeling May 08

 

GRATIS 3 - Ecstasy (MDMA): pharmacological and toxic effects, mechanism of action and clinical management

XAVIER, Caroline Addison Carvalho, LOBO, Patrícia Leal Dantas, FONTELES, Marta Maria de França et al

Rev. psiquiatr. clín., 2008, vol.35, no.3, p.96-103

.

Regresar a RESÚMENES JULIO 2008

.

© 1999-2008 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.